Ҵý

Trusted by:

clients clients clients clients clients clients clients clients clients clients
Released: 5-May-2025 6:45 PM EDT
Phage Therapy May Treat Drug Resistance in Patients With Cystic Fibrosis, Study Finds
Yale School of Medicine

Antimicrobial resistance, in which germs like bacteria and fungi no longer respond to medicines, is a rising global threat. When antibiotics and other drugs become ineffective, infections can become difficult or impossible to treat, leading to an increase in the spread and severity of disease.

Released: 5-May-2025 6:35 PM EDT
Improved Breast Cancer Outcomes with Less Invasive Surgery
Yale Cancer Center/Smilow Cancer Hospital

A breast cancer surgeon and director of the Hispanic Breast Cancer Program at Smilow Cancer Hospital at Fairfield/Bridgeport, Dr. Monica Valero also sees patients at Smilow Cancer Hospital at New Haven and Trumbull. Before joining the Yale Cancer Center and Smilow, Dr. Valero was on faculty at Beth Israel Deaconess Medical Center.

Ҵý: Researchers May Have Found a Way to Mitigate or Eliminate Excessive Scarring During Wound Healing
Released: 5-May-2025 6:20 PM EDT
Researchers May Have Found a Way to Mitigate or Eliminate Excessive Scarring During Wound Healing
University of California, Los Angeles (UCLA), Health Sciences

The findings could lead to a new way to reduce or prevent excessive scarring, which could benefit patients recovering from surgery, injuries, or burns.

Released: 5-May-2025 6:05 PM EDT
Trying to Predict How an Autistic Child Will Develop Cognitively
Universite de Montreal

Although autism can be diagnosed very early, it remains difficult to plot a child's developmental trajectory. Now a team of UdeM-affiliated researchers is working to remedy this, via AI and genomics.

Ҵý: Researchers Raise Red Flag about AI-Generated Fake Images in Biomedical Research
Release date: 5-May-2025 5:30 PM EDT
Researchers Raise Red Flag about AI-Generated Fake Images in Biomedical Research
Sbarro Health Research Organization (SHRO)

“Generative Artificial Intelligence can be exploited to produce fraudulent scientific images,” say the authors of an editorial published in the American Journal of Hematology (AJH), “either from scratch or by modifying existing visual materials to increase the realism of the final fabricated product.”

Release date: 5-May-2025 5:30 PM EDT
CHLA Study Finds Aqueous Humor Liquid Biopsy is Safe for Children With Retinoblastoma
Children's Hospital Los Angeles

Liquid biopsy was pioneered at Children’s Hospital Los Angeles as an effective test for retinoblastoma, the most common eye cancer in babies and toddlers. Traditional biopsy is invasive and risks spreading cancer outside the eye. The CHLA researchers found that using aqueous humor—the clear fluid of the eye—could safely diagnose retinoblastoma and in 2023, launched the CAP/CLIA-validated LBSeq4Kids liquid biopsy clinical test.

Not for public release

This news release is embargoed until 5-May-2025 5:00 PM EDT Released to reporters: 29-Apr-2025 9:40 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 5-May-2025 5:00 PM EDT The Ҵý PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 5-May-2025 5:00 PM EDT Released to reporters: 29-Apr-2025 9:35 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 5-May-2025 5:00 PM EDT The Ҵý PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 5-May-2025 5:00 PM EDT Released to reporters: 29-Apr-2025 9:40 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 5-May-2025 5:00 PM EDT The Ҵý PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 5-May-2025 5:00 PM EDT Released to reporters: 29-Apr-2025 9:35 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 5-May-2025 5:00 PM EDT The Ҵý PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


close
1.20231